Jennison Associates LLC Adverum Biotechnologies, Inc. Transaction History

Jennison Associates LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 Apr 20, 2018	SELL	$3.65 - $7.95 $1.1 Million - $2.4 Million	-302,083 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$2.85 - $3.95 $860,936 - $1.19 Million	302,083	302,083 $1.06 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.